Are you Dr. Lele?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
800 Rose Street
Lexington, KY 40536Phone+1 859-323-5424Fax+1 859-257-7899
Summary
- Dr. Subodh Lele, MD is a board certified pathologist in Lexington, Kentucky. He is currently licensed to practice medicine in Kentucky, Arizona, and Iowa. He is affiliated with Nebraska Medicine - Nebraska Medical Center and Nebraska Medicine - Bellevue.
Education & Training
- University of Texas Medical Branch HospitalsResidency, Pathology-Anatomic and Clinical, 1997 - 2000
- SUNY Downstate Health Sciences UniversityResidency, Pathology-Anatomic and Clinical, 1993 - 1997
- Seth G.S. Medical CollegeClass of 1989
Certifications & Licensure
- NE State Medical License 2006 - 2026
- IA State Medical License 2014 - 2025
- AZ State Medical License 2014 - 2016
- KY State Medical License 2000 - 2007
- PA State Medical License 1997 - 2000
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer.Sakthivel Muniyan, Raghupathy Vengoji, Rama Krishna Nimmakayala, Parthasarathy Seshacharyulu, Balaji Perumalsamy
Cancer Letters. 2025-01-28 - Oncogenic potential of truncated-Gli3 via the Gsk3β/Gli3/AR-V7 axis in castration-resistant prostate cancer.Jyoti B Kaushal, Pratima Raut, Sushanta Halder, Zahraa W Alsafwani, Seema Parte
Oncogene. 2025-01-16 - Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers.Sreyashi Bhattacharya, Hannah L Harris, Ridwan Islam, Sanika Bodas, Navatha Polavaram
Cell Death & Disease. 2024-08-25